blog title1

Maxhealth Innovative Meditech (Wuxi) LtdMei'an Innovative Medical Technology Wuxi Co., Ltd. has established a strategic partnership with RD Biomed, a UK-based company (Mei'an Holding's overseas R&D institution), and successfully developed the Peptest pepsin detection kit (colloidal gold method). This reagent is the world's first non-invasive diagnostic test for reflux disease and has been widely used in clinical settings both domestically and internationally. This product is a low-cost, rapid, and highly sensitive and specific test developed for GERD. It is non-invasive, easy to use, and painless for patients; it has a wide range of applications and can quickly identify symptoms, diagnosing both esophageal and extra-esophageal reflux diseases.  In particular, its sensitivity and specificity are far superior to existing diagnostic methods.